Patent · US Active

Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

US10570115B2 · kind B2 · utility

21Cited by
15References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2017
Grant dateFeb 25, 2020
Priority date—
Expiry dateSep 29, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I: pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.